These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23995153)

  • 21. Metabolic syndrome (MetS) in Lebanese patients with schizophrenia receiving atypical antipsychotic drugs.
    Bou Khalil R; Rohayem J; Abou Said N; El Chammay R; Haddad R; Richa S
    Asian J Psychiatr; 2013 Feb; 6(1):88-9. PubMed ID: 23380330
    [No Abstract]   [Full Text] [Related]  

  • 22. A population-based cohort study to elucidate temporal relationship between schizophrenia and metabolic syndrome (KCIS no. PSY3).
    Chang JC; Yen AM; Lee CS; Chen SL; Chiu SY; Fann JC; Chen HH
    Schizophr Res; 2013 Dec; 151(1-3):158-64. PubMed ID: 24103573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study.
    Srisurapanont M; Likhitsathian S; Boonyanaruthee V; Charnsilp C; Jarusuraisin N
    BMC Psychiatry; 2007 Apr; 7():14. PubMed ID: 17448257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and metabolic syndrome in a psychiatric rehabilitation service.
    Tirupati S; Chua LE
    Aust N Z J Psychiatry; 2007 Jul; 41(7):606-10. PubMed ID: 17558623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Metabolic syndrome in schizophrenia].
    Nyboe L; Videbech P
    Ugeskr Laeger; 2010 Dec; 172(49):3399-404. PubMed ID: 21129316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome, anxiety, depression and suicidal tendencies in post-traumatic stress disorder and schizophrenic patients.
    Maslov B; Marcinko D; Milicevic R; Babić D; Dordević V; Jakovljević M
    Coll Antropol; 2009 Dec; 33 Suppl 2():7-10. PubMed ID: 20120396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome in patients with psychotic disorders: diagnostic issues, comorbidity and side effects of antipsychotics.
    Kozumplik O; Uzun S; Jakovljević M
    Psychiatr Danub; 2010 Mar; 22(1):69-74. PubMed ID: 20305594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.
    van Winkel R; De Hert M; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
    Bipolar Disord; 2008 Mar; 10(2):342-8. PubMed ID: 18271914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular risks of atypical antipsychotic drug treatment.
    Drici MD; Priori S
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):882-90. PubMed ID: 17563919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data.
    Puenpatom RA; Victor TW
    Postgrad Med; 2009 Nov; 121(6):9-20. PubMed ID: 19940413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical health and schizophrenia.
    Mitchell AJ; Malone D
    Curr Opin Psychiatry; 2006 Jul; 19(4):432-7. PubMed ID: 16721177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review.
    Wysokiński A; Kowman M; Kłoszewska I
    Psychiatr Danub; 2012 Sep; 24(3):314-22. PubMed ID: 23013638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.
    Najarian RM; Sullivan LM; Kannel WB; Wilson PW; D'Agostino RB; Wolf PA
    Arch Intern Med; 2006 Jan; 166(1):106-11. PubMed ID: 16401818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of metabolic syndrome in patients with schizophrenia in India.
    Grover S; Aggarwal M; Dutt A; Chakrabarti S; Avasthi A; Kulhara P; Somaiya M; Malhotra N; Chauhan N
    Psychiatry Res; 2012 Dec; 200(2-3):1035-7. PubMed ID: 22503355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mental disorders and metabolic syndrome: a fatamorgana or warning reality?
    Jakovljević M; Crncević Z; Ljubicić D; Babić D; Topić R; Sarić M
    Psychiatr Danub; 2007 Jun; 19(1-2):76-86. PubMed ID: 17603420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia.
    Mulder H; Franke B; van der-Beek van der AA; Arends J; Wilmink FW; Scheffer H; Egberts AC
    J Clin Psychopharmacol; 2007 Aug; 27(4):338-43. PubMed ID: 17632216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder.
    Chiu CC; Chen CH; Huang MC; Chen PY; Tsai CJ; Lu ML
    J Clin Psychopharmacol; 2012 Oct; 32(5):585-92. PubMed ID: 22926590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Easy and low-cost identification of metabolic syndrome in patients treated with second-generation antipsychotics: artificial neural network and logistic regression models.
    Lin CC; Bai YM; Chen JY; Hwang TJ; Chen TT; Chiu HW; Li YC
    J Clin Psychiatry; 2010 Mar; 71(3):225-34. PubMed ID: 19814949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome and short-term heart rate variability in adults with intellectual disabilities.
    Chang YW; Lin JD; Chen WL; Yen CF; Loh CH; Fang WH; Wu LW
    Res Dev Disabil; 2012; 33(6):1701-7. PubMed ID: 22684003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.